Dichloromethane → (E)-3-(6,6-dimethyl-7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylic acid hydrochloride

HRID 1362459Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1362459
[CH3:1][C:2]1([CH3:22])[C:11](=[O:12])[NH:10][C:9]2[N:8]=[CH:7][C:6](/[CH:13]=[CH:14]/[C:15]([O:17]C(C)(C)C)=[O:16])=[CH:5][C:4]=2[CH2:3]1.C(O)(C(F)(F)F)=O.C(Cl)[Cl:31]>>[ClH:31].[CH3:1][C:2]1([CH3:22])[C:11](=[O:12])[NH:10][C:9]2[N:8]=[CH:7][C:6](/[CH:13]=[CH:14]/[C:15]([OH:17])=[O:16])=[CH:5][C:4]=2[CH2:3]1

Komponenten

4

Versuchsvorschrift

A solution of (E)-tert-butyl 3-(6,6-dimethyl-7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylate (165 mg, 0.55 mmol) in CH2Cl2 (10 mL) was treated with TFA (10 mL). After stirring at room temperature for 2 h, the solution was concentrated in vacuo. The resulting crude product was treated with anhydrous HCl in dioxane (4 mL, 4.0 M) and sonicated for 15 min. The off-white solid product was then isolated by filtration and dried under vacuum. Yield: 152 mg (quant); 1H NMR (300 MHz, DMSO-d6) δ 10.71 (s, 1H), 8.38 (s, 1H), 8.04 (s, 1H), 7.56 (d, J=16.1 Hz, 1H), 6.54 (d, J=16.1 Hz, 1H), 2.81 (s, 2H), 1.09 (s, 6H); ESI MS m/z 247 [C13H14N3O4+H]+

Aufarbeitung

  1. concentrationthe solution was concentrated in vacuo
  2. additionThe resulting crude product was treated with anhydrous HCl in dioxane (4 mL, 4.0 M)
  3. customsonicated for 15 min
  4. customThe off-white solid product was then isolated by filtration
  5. customdried under vacuum

Quellen und Nachweise

ORD-Eintrag
ord-b7c7046d509c41f2bb24d724ca4cb5c9
Quelldatensatz
uspto-grants-2011_02
Patentnummer
US07879872B2

Notizen zur Reaktion

Wird geladen…